2018 RNS Forum-Series
Course

2018 Forum Series Part 2

This course will allow you to gain greater knowledge and skill about Spondyloarthropathies (SpA), Reactive Arthritis (ReA), Inflammatory Bowel Disease (IBD), and more, to apply to your daily practice.

0 out of 8 steps completed0%
0 Lessons

Start Course

Course Summary

The 2018 Forum Series is a two day evidence-based accredited continuing education and networking experience that equips rheumatology nurses to deepen their effectiveness in all healthcare settings, provide information on the role of rheumatology nurses and advanced practice providers, and point them to innovative strategies for transforming rheumatology practice. You will gain greater knowledge and skill about Spondyloarthropathies (SpA), Reactive Arthritis (ReA), Inflammatory Bowel Disease (IBD), and more, to apply to your daily practice.

Target Audience

This activity has been designed to meet the educational needs of nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate.

Learning Objectives

  • Essentials – Enhance knowledge and abilities associated with the basic topics of immunology, pharmacology, physical assessments, and infusion care from beginner and advanced perspectives of the RN, APRN, and PA in rheumatology.
  • Evaluations – Evaluate and incorporate into practice current state of the science and research in several common and rare rheumatologic diseases.
  • Efficiencies – Explore strategic knowledge about the clinical application of existing and emerging treatment guidelines, therapeutic options, and presentation of rheumatologic diseases while demonstrating skills learned through group case studies and discussion that will help enhance clinical competency and decision-making ability.
  • Evidences – Examine best practice evidence that supports and promotes the roles of the RN, APRN, and PA in rheumatology.
  • Engagements – Engage through formal and informal opportunities for collegial exchange, learning gamification, innovative educational tactics, and group case study discovery.

Accreditation Statement

Rheumatology Nurses Society is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500).

Rheumatology Nurses Society designates this educational activity for 4.75 total contact hours and 2 CNE pharmacotherapeutic contact hours.

Faculty Disclosures

According to the disclosure policy of the Rheumatology Nurses Society, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.

Betsy Kirchner, CNP, RN-BC
Speakers Bureau: Merck, Regeneron
Consultant: Celgene, Regeneron

Linda Grinnell-Merrick, MS, NP-BC
Speakers Bureau: Abbvie, Celgene, Janssen, Novartis, Sanofi
Consultant: Abbvie, Celgene, Lily, Pfizer, Sanofi

Eileen J. Lydon, MA, RN, ANP-BC
Speakers Bureau: Abbvie, Novartis
Consultant: Celgene, Horizon, Sanofi

Amanda Mixon, PA-C
Speakers Bureau: Abbvie, Celgene, Janssen, Lilly, Novartis
Consultant (Ad board): Abbvie, Celgene, Lilly, Novartis, Pfizer, Regeneron

Monica Richey, MSN, ANP-BC/GNP
Speakers Bureau: Mallinckrodt
Consultant: Celgene, Novartis

Copyright Statement

© 2019. This CNE-certified activity is held as copyrighted © by Rheumatology Nurses Society. Through this notice, the Rheumatology Nurses Society grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).